Policy & Market
Sep 28, 2026 · 1 min read · 77,313 views
US trade officials hear case on declining German drug prices
D
Daniel Park
Editorial · Sep 28, 2026
American trade officials on Tuesday heard testimony for and against an investigation linked to Germany's declining payments for drugs, as EU-based pharma executives are pushing for more competitiveness with the US and China. The
← Previous
A Parkinson's biotech debut, fundraising campaign and licensing deal
Next →
Roche kidney drug's Phase 3 win sets up path to accelerated approval
